Inhalable Drugs Market Revenue & Gross Margin Analysis 2019: GlaxoSmithKline, Pfizer, Aradigm, Novartis
Inhalable Drug is a medicine that is inhaled directly into the lungs to achieve higher curing efficiency. Global inhalable drugs market is expected to witness a growth in the forecasted period owing to rising prevalence of chronic diseases such as tuberculosis, cancer and increasing geriatric population.
View full press release